Literature DB >> 6421984

Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function.

A Moretta, G Pantaleo, M C Mingari, L Moretta, J C Cerottini.   

Abstract

In an attempt to define the requirement of T8, T4, and T3 surface molecules in functional interactions occurring between human cytolytic T lymphocytes (CTL) and specific target cells, we have analyzed a large number of CTL clones derived from primary mixed lymphocyte culture (MLC) T cell populations for their susceptibility to inhibition by monoclonal antibodies (mAb) directed against these surface antigens. In most experiments, MLC T cells were stained with B9.4 (anti-T8) or OKT4 (anti-T4) mAb, separated into positive and negative cells using a fluorescence-activated cell sorter (FACS) and cloned under limiting conditions. While the lytic activity of the majority of T8+ CTL clones was inhibited by B9.4 mAb, approximately 15% of these clones were unaffected even in the presence of excess antibody. Flow cytofluorometric analysis of T8 antigen in individual clones did not show any correlation between the amount of T8 antigen expressed, the magnitude of cytolytic activity and the susceptibility (or lack thereof) to inhibition by B9.4 mAb. Of the 16 T4+ CTL clones analyzed, 7 were resistant to inhibition by OKT4 mAb even at doses 10-fold higher than that sufficient for complete inhibition of susceptible clones. Again, no correlation was found between the amount of T4 antigen expressed and the susceptibility to inhibition by the corresponding antibody. The same sets of T8+ and T4+ CTL clones were also analyzed for their susceptibility to inhibition by OKT3 mAb. Although all of the clones expressed the T3 surface antigen, only 15/23 T8+ clones and 9/14 T4+ clones were inhibited by anti-T3 mAb. To further document this clonal heterogeneity, we selected two T3+ T4- T8+ CTL clones that had no concomitant NK-like activity. One clone was resistant to inhibition by OKT3 mAb, whereas the other was highly susceptible. Incubation with OKT3 mAb resulted in modulation of the T3 molecules in both clones. Following modulation, however, the cytolytic activity of the resistant clones was unaffected, whereas the lytic activity of the susceptible clone was abrogated. These results thus indicate extensive clonal heterogeneity in the requirement for T3, T4, and T8 molecules in CTL function. Moreover, it appears that T3 molecules are not always physically and functionally linked to CTL receptor structures.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6421984      PMCID: PMC2187241          DOI: 10.1084/jem.159.3.921

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?

Authors:  T W Chang; P C Kung; S P Gingras; G Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

2.  Inhibition of T cell-mediated cytolysis by monoclonal antibodies directed against Lyt-2: heterogeneity of inhibition at the clonal level.

Authors:  H R MacDonald; N Thiernesse; J C Cerottini
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

Review 3.  Human T lymphocyte antigens as defined by monoclonal antibodies.

Authors:  B F Haynes
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

4.  Human spleen as a source of T cell growth factor.

Authors:  A Moretta; M Colombatti; B Chapuis
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

5.  Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen.

Authors:  R L Evans; D W Wall; C D Platsoucas; F P Siegal; S M Fikrig; C M Testa; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

6.  Human T cell subpopulations defined by a monoclonal antibody. II. Evidence for cell cooperation in the response to alloantigens and generation of cytolytic cells.

Authors:  A Moretta; G Corte; M C Mingari; L Moretta
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

7.  Phenotypic characterization of human cytolytic T lymphocytes in mixed lymphocyte culture.

Authors:  A Moretta; M C Mingari; B F Haynes; R P Sekaly; L Moretta; A S Fauci
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

8.  Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones.

Authors:  S C Meuer; J C Hodgdon; R E Hussey; J P Protentis; S F Schlossman; E L Reinherz
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

9.  Idiotype-like molecules on cells of a human T cell leukemia.

Authors:  R D Bigler; D E Fisher; C Y Wang; E A Rinnooy Kan; H G Kunkel
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

10.  Surface markers of cloned human T cells with various cytolytic activities.

Authors:  L Moretta; M C Mingari; P R Sekaly; A Moretta; B Chapuis; J C Cerottini
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Cytotoxic effector cells of the immune system.

Authors:  P Groscurth
Journal:  Anat Embryol (Berl)       Date:  1989

2.  Lymphokine-activated-killer-mediated lysis of cells infected with typhus group rickettsiae can be inhibited by OKT3 monoclonal antibody.

Authors:  M Carl; G A Dasch
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

3.  MHC-unrestricted cytolytic T lymphocytes.

Authors:  A M Krensky; C Clayberger
Journal:  Surv Immunol Res       Date:  1985

4.  Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line.

Authors:  A Weiss; J D Stobo
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

5.  Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies.

Authors:  P Perez; R W Hoffman; J A Titus; D M Segal
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

6.  Gene for the human T cell differentiation antigen Leu-2/T8 is closely linked to the kappa light chain locus on chromosome 2.

Authors:  V P Sukhatme; A C Vollmer; J Erikson; M Isobe; C Croce; J R Parnes
Journal:  J Exp Med       Date:  1985-02-01       Impact factor: 14.307

7.  Expression and function of CD8 in a murine T cell hybridoma.

Authors:  S E Ratnofsky; A Peterson; J L Greenstein; S J Burakoff
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

8.  Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen-receptor complex.

Authors:  A Moretta; G Pantaleo; M Lopez-Botet; L Moretta
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

9.  Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicity.

Authors:  P Aparicio; D Jaraquemada; J A López de Castro
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

10.  P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.

Authors:  A Moretta; M Vitale; C Bottino; A M Orengo; L Morelli; R Augugliaro; M Barbaresi; E Ciccone; L Moretta
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.